新加坡 HSA 公布 Fucithalmic 1% 夫西地酸滴眼液 L54121 批次二级召回
Recall of Fucithalmic Eye Drops 1% (fusidic acid)
HSA 公布对 Fucithalmic 1% 夫西地酸滴眼液批次 L54121 的二级召回,召回日期为 2026 年 11 月 18 日,本地公司为 DCH Auriga Singapore,注册号 SIN00726P。召回原因为疑似无菌工艺模拟失败,召回范围至零售层面。HSA 要求医院、诊所和药房停止供应受影响批次,并将剩余库存退回公司。
材料列出召回批号、注册号与零售层面范围,并说明原因为疑似无菌工艺模拟失败,可供核对受影响库存。
Recall details
Date of recall: | 18 November 2026 |
Product: | Fucithalmic Eye Drops 1% |
Active Ingredient: | Fusidic acid |
Product Category: | Therapeutic Product |
Regjstration Number: | SIN00726P |
Batch No.: | L54121 |
Class of Recall: | 2 |
Level of Recall: | Retail |
Local Company: | DCH Auriga Singapore |
Description of Issue: | Suspected aseptic process simulation failure |
Recall Instructions: | Hospitals, clinics, pharmacies: Stop supplying the affected batch and return the remaining stocks to the company |
Note:
The Health Sciences Authority (HSA) publishes information regarding recalls of health products supplied in Singapore. These product recalls may be conducted on a company’s own initiative or upon HSA’s request to remove products where there are issues with quality, safety or efficacy.
When a recall is initiated, it does not necessarily imply that a product is considered unsafe or is inefficacious. A recall can also be initiated to remove products with quality defects that does not impact safety or efficacy from the market so as to ensure that products registered in Singapore continue to meet the stringent regulatory standards stipulated by HSA.
Not all recalls will be publicly announced via press releases. When a recall involves a product that has been widely distributed or a product that poses a serious health risk, HSA will update the public through its channels, which may include its website, social media platforms or a press release.
Class of recall
A recall is classified as Class 1 or Class 2 depending on the potential hazard of the issue.
Class 1: For recalls of products with issues that can potentially cause serious adverse health outcomes or death.
Class 2: For recalls of products with issues that would not likely cause serious adverse health outcomes.
Level of recall
The level of product recall will depend on the potential hazard of the affected product, extent of distribution and whether other mitigating measures can be taken to address the issue.
Consumer level: Affected product or batch(es) recalled from patients and consumers as well as wholesale suppliers, retail suppliers, hospitals, clinics and pharmacies.
Retail level: Affected product or batch(es) recalled from retail suppliers, hospitals, clinics and pharmacies as well as wholesale suppliers.
Wholesale level: Affected product or batch(es) recalled from wholesale suppliers.
来源:HSA 治疗药品召回 · hsa.gov.sg